Table 2b. Comparison at different thresholds between clinical and imaging grades.
| Cutoff | κ | Sensitivity | CI | Specificity | CI | LR+ | CI | LR− | CI |
|---|---|---|---|---|---|---|---|---|---|
| Proliferative vs non-proliferative | 0.617 | 0.73 | 0.65–0.79 | 0.96 | 0.95–0.97 | 18.21 | 14.23–23.30 | 0.29 | 0.22–0.37 |
| Non-STDR vs sight threatening DR | 0.476 | 0.84 | 0.81–0.87 | 0.69 | 0.67–0.72 | 2.75 | 2.52–2.99 | 0.23 | 0.19–0.28 |
| CSMO vs no CSMO | 0.440 | 0.64 | 0.57–0.71 | 0.90 | 0.89–0.92 | 6.89 | 5.78–8.22 | 0.39 | 0.33–0.48 |
| Any maculopathy vs no maculopathy | 0.440 | 0.72 | 0.68–0.76 | 0.78 | 0.76–0.80 | 3.24 | 2.91–3.60 | 0.36 | 0.32–0.42 |
Abbreviations: CI, confidence interval; LR+ and LR−, positive and negative likelihood ratios.
N=1975 for retinopathy; N=2110 for maculopathy.